Flunixin Injection

A sterile aqueous solution for injection.

Flunixin Injection is indicated for use in cattle and horses in the alleviation of inflammation and pain. In the horse, Flunixin Injection is indicated for the alleviation of inflammatory signs associated with musculo-skeletal disorders and for the alleviation of visceral pain associated with colic. In cattle, Flunixin Injection is indicated for the control of acute inflammation associated with respiratory disease. Flunixin Injection has also been shown to have some benefit in the treatment of acute pulmonary emphysema [fog fever] and as adjunctive therapy in the treatment of acute mastitis. In pigs, Flunixin Injection is indicated as an adjunctive therapy in the treatment of swine respiratory diseases.

Flunixin Injection is indicated for intravenous administration to cattle and horses and intramuscular injection to pigs. Horses: For use in equine colic, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight. Treatment may be repeated once or twice if colic recurs. During clinical trials, approximately 10% of the horses required one or two additional treatments. The cause of colic should be determined and treated with concurrent therapy. For use in musculo-skeletal disorders, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight, once daily for up to 5 days according to clinical response.
Cattle: For use in acute inflammatory conditions, the recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight. Repeat as necessary at 24 hour intervals for up to 5 consecutive days.
Pigs: For use in pigs, the recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight once by intramuscular injection. Flunixin Injection should be administered as adjunctive therapy in conjunction with a suitable course of antibacterial therapy.